Abstract:The crystal structure of the (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one has been determined by single crystal X-ray diffraction method. The compound crystallizes in the monoclinic system, space group P2(1) with a = 11.867(4) angstrom, b = 5.6968(19) angstrom, c = 20.258(7) angstrom, alpha = 90.00 degrees, beta = 91.866(4)degrees, gamma = 90.00 degrees, Z = 4, V = 1368.8(8) angstrom(3), Dx = 1.520 Mg/m(3), F-(000) = 632, mu(MoKa) = 0.157 mm(-1), R = 0.0562 and wR = 0.1744 for 3675 reflections with I > 2 sigma(I). X-Ray analysis reveals that the benzene and oxazolidin rings are non-coplanar. The oxazolidin ring displays a twist conformation. The two molecules interact with each other by two strong N-H center dot center dot center dot O hydrogen bonds. Herein, we report the synthesis and crystal structure of (4S, 5R)-5-[3,5-bis(trifluoromethyl) phenyl]-4-methyl-1,3-oxazolidin-2-one.

(3′S,4R)-3-(3′-Cyclopentyl-3′-phenylpropanoyl)-5, 5-dimethyl-4-phenyl-1,3-oxazolidin-2-one

(3′R,4s)-3-(3′-cyclohexyl-3′-phenylpropionyl)-5,5-dimethyl-4-phenyloxazolidin-2-one

(2S,4s)-2-[(s,e)-2-bromo-1-nitromethyl-3-phenylallyl]-4-methylcyclohexanone

Synthesis and Crystal Structure Characterization of (1R,2R,3R,5S)-3-(3-chlorophenyl)-1-hydroxy-2-methyl-6-phenyl-8-oxa-6-azabicyclo[3.2.1]octan-7-one

(1′S,2′s,5′r)-3-(2-bromopropionyl)-2′-isopropyl-5′-methylspiro[2h-1,3-benzoxazine-2,1′-cyclohexan]-4(3h)-one

(1<i>S</i>,4a<i>R</i>,5<i>S</i>,6<i>S</i>,8a<i>R</i>*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexahydro-1<i>H</i>-2,3-benzoxazin-4-one

(R)-3-[(e)-3-(2-furyl)acryloyl]-5,5-dimethyl-4-phenyloxazolidin-2-one

(5R,6r)-Methyl 6-Methyl-2-phenyl-5,6dihydro-4h-1,3-oxazine-5-carboxylate

(4r)-5,5-Dimethyl-4-Phenyl-3-[(E)-3-Phenylacryloyl]-1,3-Oxazolidin-2-One

(1 R ,2 S ,5 R )-2-Isopropyl-5-methylcyclohexyl (2 S ,3 S )-3-phenyloxirane-2-carboxylate

(1S,4aR,5S,6S,8aR*)-3-Benzyl-1-methyl-5,6-diphenyl-3,4,4a,5,6,8a-hexa-hydro-1H-2,3-benzoxazin-4-one.

(3ar,6s,7s,7ar)-2-(4-Methoxybenzyl)-7-(4-Nitrophenyl)-6-Phenyl-3a,6, 7,7a-Tetrahydroisoindolin-1-One

(3R)-Methyl 3-[(2S)-4,6-dimethoxy-2-(4-methoxyphenyl)-3-oxo-2,3-dihydro-1-benzofuran-2-yl]-2-methoxycarbonyl-3-phenylpropionate

(1r,2s,5r)-2-Isopropyl-5-Methylcyclohexyl (2s,3s)-3-Phenyloxirane-2-Carboxylate

2-(3,5-Dimethylphenyl)-5-(4-ethylphenyl)-1,3,4-oxadiazole

(3Ar,5r)-5-(4-chlorophenyl)-1,2,3,3a-tetrahydrobenzo[e]pyrrolo[2,1-b][ 1,3]Oxazepin-10(5H)-one

3-(4-Methoxystyryl)-2h-1,4-benzoxazin-2-one

{(1R,3s)-3-[(dimethylamino)methyl]-2,2-dimethylcyclopropyl}diphenylmethanol

(R,S)-Methyl 3-methyl-5-oxo-1-phenylcyclo-hex-3-ene-1-carboxylate

5-Methyl-1,2,3,3a-tetrahydrobenzo[e]pyrrolo[2,1-b][1,3]oxazepin-10(5h)-one

Synthesis and Crystal Structure of (4S,5r)-5-[3,5-bis(trifluoromethyl)phenyl]-4-methyl-1,3-oxazolidin-2-one